Night Respite for Postpartum Mothers With SUD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-20

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single arm pilot feasibility study will evaluate the implementation of overnight infant respite care and parenting skills to mothers with substance use disorders in the early postpartum period residing in residential substance use disorder treatment programs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

NCT06576323

Opioid Use Disorder Neonatal Abstinence Syndrome

RECRUITING NA

Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction

NCT02057627

Postpartum Depression

COMPLETED NA

Postpartum Intervention for Mothers With Opioid Use Disorders

NCT05614661

Opioid Use Disorder

RECRUITING NA

Prevention of Postpartum Depression in Low-Income Women

NCT00053651

Depression, Postpartum

COMPLETED PHASE1

Reducing Maternal Depression and Promoting Infant Social-Emotional Health & Development

NCT03464630

Maternal Depression and Parent Practices, Postpartum Infant Development

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This single arm pilot feasibility study will evaluate the implementation of overnight infant respite care provided approximately 3 nights per week for 6 weeks (18 nights total) to each of 20 - 25 mothers with substance use disorders in the early postpartum period residing in residential substance use disorder treatment programs. Overnight respite care will last for eight hours, with one hour reserved each morning to provide teaching about infant-specific temperament and cues. The program is a unique public/private/academic partnership with the Massachusetts Department of Children and Families (DCF), Boston Baby Nurse and Nanny (BBNN), two residential treatment programs, and Massachusetts General Hospital.

Partnering with BBNN, Newborn Care Experts interested in providing respite care to families impacted by SUD will be paired with postpartum families residing in two residential treatment programs in the Boston area. New Day in Somerville, MA and Entre Familia in Mattapan, MA will partner with MGH to recruit individuals to complete a screening and baseline intake, receive night respite care, and complete a follow up study visit at the completion of the intervention and at 3 months post intervention.

This study will use mixed methods to understand the feasibility and acceptability of the pilot intervention including experiences of this pilot program through the perspectives of program participants, respite care givers, residential treatment overnight staff, and study staff. Respite caregivers and residential treatment program staff will be invited to participate in interviews after each dyad receives their allotted hours of respite care to reflect on this program participant's specific experience.

BBNN, DCF, and residential treatment program leadership staff, will be invited to participate a focus group once at the completion of the study to understand the feasibility, acceptability, and implementation of this program through the lens of their organizations. They will also be invited to take a short survey aimed at assessing their perception of the intervention's appropriateness and feasibility.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use Disorder Maternal Drugs Affecting Fetus Postpartum Mood Disturbance Sleep Disorder Neonatal Opioid Withdrawal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Overnight infant respite care provided approximately 3 nights per week for 6 weeks (18 nights total) lasting eight hours per night. Overnight respite care will last for eight hours, with one hour reserved to provide teaching about infant-specific temperament and cues.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Night Respite Care

18 overnight night respite care sessions over six weeks with parental skills provided through teachable moments before and after respite care supports

Group Type EXPERIMENTAL

Night Respite Care

Intervention Type BEHAVIORAL

(see description above)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Night Respite Care

(see description above)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caring for an infant under 12 months of age.
* Being the primary caretaker for their infant.
* Having a DSM-5 diagnosis of a substance use disorder.
* Currently residing in a participating residential treatment program or private home setting
* English-speaking or Spanish-speakers with limited English proficiency

Exclusion Criteria

* Having an untreated serious mental health illness.
* Having an untreated substance use disorder or existing concerns that this person is actively using substances.
* Having a history of prior violence or intimate partner violence in the home.
* Provider concern regarding instability or lack of information about home safety.
* Not actively parenting an infant under 12 months of age

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No